Opportunities center on automated, closed, single-use and at-line sampling, driven by sterility rules, cell and gene therapies, PAT, electronic traceability and Asia-Pacific expansion.Dublin, Oct. 01, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results